Literature DB >> 2216712

Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector.

K H Mellits1, T Pe'ery, L Manche, H D Robertson, M B Mathews.   

Abstract

Bacteriophage RNA polymerases are widely used to synthesize defined RNAs on a large scale in vitro. Unfortunately, the RNA product contains a small proportion of contaminating RNAs, including complementary species, which can lead to errors of interpretation. We cloned the gene encoding Ad2 VA RNAI into a vector containing a T7 RNA polymerase promoter in order to generate large quantities of VA RNA for the study of its interaction with the dsRNA-dependent protein kinase DAI. Exact copies of VA RNAI were synthesized efficiently, but were contaminated with small amounts of dsRNA which activated DAI and confounded interpretation of kinase assays. We therefore developed a method to remove the dsRNA contaminants, allowing VA RNAI and mutants to be tested for their ability to activate or inhibit DAI. This method appears to be generally applicable.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2216712      PMCID: PMC332216          DOI: 10.1093/nar/18.18.5401

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  Interaction of adenovirus VA RNAl with the protein kinase DAI: nonequivalence of binding and function.

Authors:  K H Mellits; M Kostura; M B Mathews
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

2.  A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure.

Authors:  E T Schenborn; R C Mierendorf
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

3.  Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase.

Authors:  J Kitajewski; R J Schneider; B Safer; S M Munemitsu; C E Samuel; B Thimmappaya; T Shenk
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

4.  A mechanism for the control of protein synthesis by adenovirus VA RNAI.

Authors:  R P O'Malley; T M Mariano; J Siekierka; M B Mathews
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  Escherichia coli ribonuclease III cleavage sites.

Authors:  H D Robertson
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

7.  Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements.

Authors:  J J Dunn; F W Studier
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

8.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.

Authors:  M J Zoller; M Smith
Journal:  DNA       Date:  1984-12

9.  Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus.

Authors:  R A Bhat; B Thimmappaya
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

10.  Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity.

Authors:  M G Katze; D DeCorato; B Safer; J Galabru; A G Hovanessian
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  31 in total

1.  The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR.

Authors:  Jean M Nussbaum; Shobha Gunnery; Michael B Mathews
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

2.  Plasmid cDNA-directed protein synthesis in a coupled eukaryotic in vitro transcription-translation system.

Authors:  D Craig; M T Howell; C L Gibbs; T Hunt; R J Jackson
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

3.  Interactions between double-stranded RNA regulators and the protein kinase DAI.

Authors:  L Manche; S R Green; C Schmedt; M B Mathews
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Role of the apical stem in maintaining the structure and function of adenovirus virus-associated RNA.

Authors:  K H Mellits; T Pe'ery; M B Mathews
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Transfection of HepG2 cells with infectious hepatitis C virus genome.

Authors:  S Dash; A B Halim; H Tsuji; N Hiramatsu; M A Gerber
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

6.  Suppression of RNA interference by adenovirus virus-associated RNA.

Authors:  M Gunnar Andersson; P C Joost Haasnoot; Ning Xu; Saideh Berenjian; Ben Berkhout; Göran Akusjärvi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI.

Authors:  P A Clarke; M Schwemmle; J Schickinger; K Hilse; M J Clemens
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

8.  Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR.

Authors:  Sean A McKenna; Darrin A Lindhout; Takashi Shimoike; Colin Echeverría Aitken; Joseph D Puglisi
Journal:  J Mol Biol       Date:  2007-06-15       Impact factor: 5.469

9.  Double-stranded RNA-activated protein kinase (PKR) is negatively regulated by 60S ribosomal subunit protein L18.

Authors:  K U Kumar; S P Srivastava; R J Kaufman
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

10.  RNA dimerization promotes PKR dimerization and activation.

Authors:  Laurie A Heinicke; C Jason Wong; Jeffrey Lary; Subba Rao Nallagatla; Amy Diegelman-Parente; Xiaofeng Zheng; James L Cole; Philip C Bevilacqua
Journal:  J Mol Biol       Date:  2009-05-13       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.